Bard Associates’s Stride LRN Stock Holding History

Bard Associates’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.2K	Buy	1,023 +28	+3%	+$2.57K	0.02%	163
2026 Q1	$87.7K	Buy	+995	New	+$80.7K	0.02%	158

Other funds holding LRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bard Associates's LRN Position: Q2 2026 in Review

Bard Associates increased its Stride (LRN) stake by 2.8% in Q2 2026, buying an estimated $2.57K and bringing the position to 1,023 shares worth $88.2K. The position accounts for 0.02% of the portfolio, ranked #163.

Bard Associates first reported a position in LRN in Q1 2026 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

Bard Associates held 1,023 shares of Stride worth $88.2K as of Q2 2026.
Bard Associates bought 28 Stride shares in Q2 2026, an estimated $2.57K.
Stride made up 0.02% of Bard Associates's portfolio in Q2 2026, its #163 holding.
Bard Associates first reported a position in Stride in Q1 2026 and has held it in 2 quarters since.
414 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.